Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Is there a role for testosterone therapy in premenopausal women?

Shifren JL.

Menopause. 2003 Sep-Oct;10(5):383-4. No abstract available.

PMID:
14501596
2.

The role of androgens in hormone replacement therapy.

Johnson CE, Berman JR.

Expert Opin Pharmacother. 2005 Sep;6(11):1815-31. Review.

PMID:
16144503
3.

Testosterone therapy in premenopausal women.

Kalantaridou SN, Calis KA.

Semin Reprod Med. 2006 Apr;24(2):106-14. Review.

PMID:
16633984
4.

Testosterone replacement therapy in the climacteric: benefits beyond sexuality.

Maia H Jr, Casoy J, Valente J.

Gynecol Endocrinol. 2009 Jan;25(1):12-20. doi: 10.1080/09513590802360744. Review.

PMID:
19165658
5.
6.

[Androgens, well-being and libido in women].

van Santbrink EJ, Gianotten WL, Fauser BC.

Ned Tijdschr Geneeskd. 2003 Sep 27;147(39):1899-904. Review. Dutch.

PMID:
14560687
7.

The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.

Krapf JM, Simon JA.

Maturitas. 2009 Jul 20;63(3):213-9. doi: 10.1016/j.maturitas.2009.04.008. Epub 2009 May 31. Review.

PMID:
19487090
8.

Androgens and the breast.

von Schoultz B.

Maturitas. 2007 May 20;57(1):47-9. Epub 2007 Mar 26. Review.

PMID:
17386984
9.

Testosterone therapy in women: a review.

Bolour S, Braunstein G.

Int J Impot Res. 2005 Sep-Oct;17(5):399-408. Review.

PMID:
15889125
10.

What is the rationale for androgen therapy for women?

Papalia MA, Davis SR.

Treat Endocrinol. 2003;2(2):77-84. Review.

PMID:
15871544
11.

Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder.

Abdallah RT, Simon JA.

Int J Impot Res. 2007 Sep-Oct;19(5):458-63. Epub 2007 Jun 21. Review.

PMID:
17581596
12.

Current and future testosterone delivery systems for treatment of the hypogonadal male.

Pfeil E, Dobs AS.

Expert Opin Drug Deliv. 2008 Apr;5(4):471-81. doi: 10.1517/17425247.5.4.471 . Review.

PMID:
18426387
13.

Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?

Schover LR.

Fertil Steril. 2008 Jul;90(1):129-40. Epub 2007 Nov 26. Review.

PMID:
18023435
14.

Safety of testosterone use in women.

Shufelt CL, Braunstein GD.

Maturitas. 2009 May 20;63(1):63-6. doi: 10.1016/j.maturitas.2009.01.012. Epub 2009 Feb 27. Review.

PMID:
19250779
15.

Pharmacological therapy for female sexual dysfunction: has progress been made?

Davis SR, Nijland EA.

Drugs. 2008;68(3):259-64. Review.

PMID:
18257605
16.

Measurement of androgens in women.

Stanczyk FZ.

Semin Reprod Med. 2006 Apr;24(2):78-85. Review.

PMID:
16633981
17.

Testosterone treatments: why, when, and how?

Margo K, Winn R.

Am Fam Physician. 2006 May 1;73(9):1591-8. Review.

18.

Male depression: a review of gender concerns and testosterone therapy.

Orengo CA, Fullerton G, Tan R.

Geriatrics. 2004 Oct;59(10):24-30. Review.

PMID:
15508552
19.

Clinical experiences with testosterone therapy: prostate safety.

Ebert T.

Aging Male. 2004 Dec;7(4):304-11. Review.

PMID:
15799126
20.

[Androgen deficiency in women: indication and risks of testosterone or DHEA treatment].

Martin-Du Pan R.

Rev Med Suisse. 2007 Mar 28;3(104):792-6. Review. French.

PMID:
17503714

Supplemental Content

Support Center